David Rickey, Director at CYTORI THERAPEUTICS, INC. (CYTX), bought 7,100 shares at $2.53 ($18K) on 2013-09-12, disclosed to the SEC on 2013-09-16.
Open-market purchase of $18k CYTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.52 | 200 | $504 | 2.8% |
| 2 | $2.53 | 1,490 | $4K | 20.8% |
| 3 | $2.54 | 610 | $2K | 8.6% |
| 4 | $2.55 | 2,800 | $7K | 39.5% |
| 5 | $2.56 | 1,100 | $3K | 15.6% |
| 6 | $2.57 | 300 |
| $771 |
| 4.3% |
| 7 | $2.58 | 600 | $2K | 8.6% |
| Total | $2.55 avg | 7,100 | $18K | 100% |
| Filing → |
| CYTX | BUY | 2015-08-31 | $17K | — | Filing → |
| CYTX | BUY | 2015-08-28 | $23K | — | Filing → |
| CYTX | BUY | 2015-08-24 | $19K | — | Filing → |